Which combination is appropriate for the treatment of moderate asthma?

Prepare for the PAEA Pediatrics EOR Exam. Study with flashcards and multiple-choice questions, each question has hints and explanations. Ace your exam!

For the treatment of moderate asthma, the recommended approach involves the use of a low dose inhaled corticosteroid (ICS) in combination with a long-acting beta-agonist (LABA). This combination is effective because the ICS targets the underlying inflammation associated with asthma, helping to reduce bronchial hyper-responsiveness and decrease the frequency of asthma attacks. The LABA complements this by providing bronchodilation, enhancing airflow and improving overall control of symptoms.

In moderate asthma, using just a short-acting beta-agonist (SABA) alone, or even just a leukotriene receptor antagonist, would not provide sufficient control of symptoms and does not address the inflammatory component adequately. High dose ICS with a SABA may also be over-treatment in the context of moderate asthma, and should typically be reserved for more severe cases. Therefore, the combination of a low dose ICS and LABA represents an effective, evidence-based strategy for managing moderate asthma.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy